Navigation Links
FlexiGel Strands® Absorbent Wound Dressing

ProductsFlexiGel Strands® Absorbent Wound Dressing
Company Smith & Nephew, Inc. - Orthopedics
Item FlexiGel Strands® Absorbent Wound Dressing
Features 
  • Highly absorbent
  • Permeable
  • Contains 20% Glycerin
  • Remains moist
  • Gently conforms to wound surface
  • Maintains Integrity
  • Gently conforms to wound space
    • Description FlexiGel Strands® Absorbent Wound Dressing is a sterile, single use bundle of absorbent matrix for use in moist wound dressing applications. The synthetic matrix absorbs excess exudate fluid, swells to conform to the wound contours, and entraps slough and necrotic debris within its strands to assist in debridement. The strands of the matrix are bound together by a matrix bridge to minimize disruption of the matrix material during use. FlexiGel Strands is flexible, pliable, and non-adherent to aid in comfort.
    Info Smith & Nephew, Inc. - Orthopedics
    Customer Service: (800) 821-5700
    Web site: http://www.smith-nephew.com/

    Related medicine products :

    1. BD Visisorb Absorbent Sticks
    2. Clo-Sur P.A.D. Nonwoven Hydrophilic Wound Dressing
    3. Pulsavac Wound Debridement System
    4. 3M™ Tegagel™ Hydrogel Wound Filler
    5. VIGILON Primary Wound Dressing
    6. 3M™ Tegagel™ Hydrogel Wound Filler with Gauze
    7. ClozeX Needleless Wound Closure Device
    8. CenterPointLock Sterile Ostomy/Wound Care Kit
    9. Wound Care Manager
    10. Cochrane Reviews in Wounds
    11. Culture, Wound
    Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 2Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 3Arrayit Diagnostics Announces Sponsored Research Agreement With Wayne State University and Arrayit Corporation 4CSHL led team discovers rare mutation dramatically increasing schizophrenia risk 10513 1CSHL led team discovers rare mutation dramatically increasing schizophrenia risk 10513 2LAs BEST Teams Up With American Chemistry Council to Educate Kids About the Benefits of a Healthy Lifestyle and a Healthy Environment 60037 1LAs BEST Teams Up With American Chemistry Council to Educate Kids About the Benefits of a Healthy Lifestyle and a Healthy Environment 60037 2LAs BEST Teams Up With American Chemistry Council to Educate Kids About the Benefits of a Healthy Lifestyle and a Healthy Environment 60037 3Brisk Walk Can Help Leave Common Cold Behind 60034 1Brisk Walk Can Help Leave Common Cold Behind 60034 2